Stéphane Le Vu
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS Research and Interventions
- SARS-CoV-2 and COVID-19 Research
- HIV/AIDS drug development and treatment
- COVID-19 Clinical Research Studies
Papers in
-
- HIV/AIDS Research and Interventions 18
- SARS-CoV-2 and COVID-19 Research 10
- HIV/AIDS drug development and treatment 3
- COVID-19 Clinical Research Studies 2
- Virology 13
- HIV Research and Treatment 13
- Co-authors
- Caroline Semaille (22 shared papers)Josiane Pillonel (18 shared papers)Françis Barin (14 shared papers)Jérémie Botton (13 shared papers)Françoise Cazein (11 shared papers)Rosemary Dray‐Spira (13 shared papers)Alain Weill (13 shared papers)Marie-Joëlle Jabagi (13 shared papers)
- Journals
- PLoS ONE (4 papers)Eurosurveillance (4 papers)AIDS (3 papers)Nature Communications (3 papers)Vaccine (3 papers)
- Partner nations
- FranceUnited KingdomUnited States
In The Last Decade
Stéphane Le Vu
53 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 75
- Virology 326
- Infectious Diseases 728
- Epidemiology 304
- Modeling and Simulation 35
- Applied Microbiology and Biotechnology 11
Countries citing papers authored by Stéphane Le Vu
This map shows the geographic impact of Stéphane Le Vu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Le Vu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Le Vu more than expected).
Fields of papers citing papers by Stéphane Le Vu
This network shows the impact of papers produced by Stéphane Le Vu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Le Vu. The network helps show where Stéphane Le Vu may publish in the future.
Co-authors
The 25 scholars most cited alongside Stéphane Le Vu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 136 | |
| 2 | 2010 | 97 | |
| 3 | 2022 | 91 | |
| 4 | 2013 | 78 | |
| 5 | 2007 | 72 | |
| 6 | 2011 | 71 | |
| 7 | 2021 | 53 | |
| 8 | 2022 | 46 | |
| 9 | 2008 | 42 | |
| 10 | 2013 | 41 | |
| 11 | 2012 | 41 | |
| 12 | 2012 | 34 | |
| 13 | 2024 | 32 | |
| 14 | 2022 | 26 | |
| 15 | 2008 | 24 | |
| 16 | 2017 | 24 | |
| 17 | 2023 | 24 | |
| 18 | 2014 | 24 | |
| 19 | 2008 | 23 | |
| 20 | 2018 | 23 |
About Stéphane Le Vu
Stéphane Le Vu is a scholar working on Infectious Diseases, Virology, Epidemiology, General Health Professions and Modeling and Simulation, having authored 54 papers that have together received 1.3k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (18 papers), HIV Research and Treatment (13 papers), HIV, Drug Use, Sexual Risk (12 papers), SARS-CoV-2 and COVID-19 Research (10 papers), Healthcare Systems and Practices (4 papers), HIV/AIDS drug development and treatment (3 papers), COVID-19 Clinical Research Studies (2 papers) and COVID-19 epidemiological studies (2 papers). The work is most often cited by research in Virology (326 citations), Infectious Diseases (728 citations), Epidemiology (304 citations), Modeling and Simulation (35 citations) and Applied Microbiology and Biotechnology (11 citations). Stéphane Le Vu has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Caroline Semaille, Josiane Pillonel, Françis Barin, Jérémie Botton, Françoise Cazein, Rosemary Dray‐Spira, Alain Weill, Marie-Joëlle Jabagi, Laurence Meyer and Mahmoud Zureik. Their work appears in journals such as PLoS ONE, Eurosurveillance, AIDS, Nature Communications and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.